These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 582138)

  • 1. Antihypertensive effect of nifedipine on conscious renal-hypertensive dogs.
    Hiwatari M; Satoh K; Taira N
    Arzneimittelforschung; 1979; 29(2):256-60. PubMed ID: 582138
    [No Abstract]   [Full Text] [Related]  

  • 2. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
    Knorr A
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
    Ishii H; Itoh K; Nose T
    Eur J Pharmacol; 1980 May; 64(1):21-9. PubMed ID: 7449813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects of nifedipine on conscious normotensive and hypertensive rats.
    Kubo T; Fujie K; Yamashita M; Misu Y
    J Pharmacobiodyn; 1981 Apr; 4(4):294-300. PubMed ID: 7264875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
    Knorr A; Stoepel K
    Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular actions of niludipine (BAY a 7168), a new dihydropyridine vasodilator, in the dog.
    Taira N; Narimatsu A; Satoh K; Himori N; Imai Y; Hiwatari M
    Arzneimittelforschung; 1979; 29(2):246-55. PubMed ID: 582137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of antihypertensive therapy on the oxygen consumption of the myocardium. III. Verapamil and nifedipine].
    Sau F; Pisano MR; Pirisi R; Seguro C; Ledda M; Raffo M; Cherchi A
    Boll Soc Ital Cardiol; 1981; 26(12):1963-71. PubMed ID: 7185368
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effects of a new dihydropyridine calcium antagonist.
    Kimura Y; Fukui H; Tanaka M; Okamoto M; Morino A; Miura A; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and hemodynamic properties of 2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine HCl (MK-761).
    Sweet CS; Scriabine A; Weitz D; Ludden CT; Minsker DH; Stone CA
    J Pharmacol Exp Ther; 1979 Oct; 211(1):200-6. PubMed ID: 114619
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K; Nonaka K; Ueno A
    Arzneimittelforschung; 1981; 31(7):1072-5. PubMed ID: 7196755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
    Tasaka K; Kamei C; Tagami H; Hokonohara T; Sugimoto Y
    Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of nifedipine--a 4-week treatment in preselected patients with coronary disease.
    Słomińska-Petelenz T; Petelenz T; Chruściel TL; Wilk J; Elertowicz M; Axenti I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):122-7. PubMed ID: 7068285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies of the antihypertensive effect of nitrendipine.
    Stoepel K; Heise A; Kazda S
    Arzneimittelforschung; 1981; 31(12):2056-61. PubMed ID: 7199297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Kawahara J; Jinno Y; Endo M; Izumi H; Takeuchi A; Izawa T
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):814-9. PubMed ID: 9234664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs.
    Karasawa A; Ikeda J; Yamada K; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1695-7. PubMed ID: 3219142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nifedipine, a new coronaroactive drug].
    Avogadro BG; Cavanna M
    Clin Ter; 1975 Jun; 73(6):581-6. PubMed ID: 1139869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.